Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B

Journal of Gastroenterology

Volumn 37, Issue 8, 2002, Pages 626-632

  Yang, Sien Sing ^a   Cheng, Ken Sheng ^b   Lai, Yung Chih ^a   Wu, Chi Hwa ^a   Chen, Tzen Kwan ^a   Lee, Chia Long ^a   Chen, Ding Shinn ^c  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute hepatic failure; Alpha fetoprotein; Hepatic encephalopathy

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; HEPATITIS B(E) ANTIGEN;

ACUTE HEPATITIS; ADULT; AGE; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; JAUNDICE; LIVER FAILURE; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; SURVIVAL; TOXIC HEPATITIS; ACUTE DISEASE; BLOOD; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING;

ACUTE DISEASE; ADULT; ALPHA-FETOPROTEINS; BILIRUBIN; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0036696878     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200099     Document Type: Article

References (35)

1. Hughes RD, Williams R. Use of bioartifical and artificial liver support devices. Semin Liv Dis 1996;16:435-44.
2. Sussman NL, Gislason GT, Kelly JH. Extracorporeal liver support. Application to fulminant hepatic failure. J Clin Gastroenterol 1994;18:320-4.
3. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liv Dis 1996;16:343-8.
4. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transplantation Surg 1999;5:29-34.
5. Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996;16:415-25.
6. McCashland TM, Shaw BW Jr, Tape E. The American experience with transplantation for acute liver failure. Semin Liver Dis 1996;16:427-33.
7. Yang SS, Chu NS, Wu CH. Subcortical somatosensory evoked potentials in patients with hepatic encephalopahty caused by severe acute hepatitis. J Gastroenterol Hepatol 1993;8:545-9.
8. Fujioka H, Kawashita Y, Kamohara Y, Yamashita A, Mizoe A, Yamaguchi J, et al. Utility of technetium-99m-labeled- galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 1999;28:329-33.
9. Shakil AO, Jones BC, Lee RG, Federle MP, Fung JJ, Rakela J. Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci 2000;45:334-9.
10. Uetsuji S, Yamamura M, Komada H, Okuda Y, Hioki K, Uedono Y, et al. Prognostic judgment of fulminant hepatitis by measurement of hepatosplenic volume ratio by computed tomography. (In Japanese with English abstract) Nippon Geka Gakkai Zasshi (J Jpn Surgical Soc) 1993;94:155-8.
11. Lee WM, Galbraith RM, Watt GH, Hughes RD, McIntire DD, Hoffman BJ, et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentration. Hepatology 1995;21:101-5.
12. Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation factors V and VIII/V ratio as predictors of outcome in paracetamol-induced fulminant hepatic failure: relationship to other prognostic indicators. Gut 1992;33:98-102.
13. Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, et al. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 1989;9:875-81.
14. Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, et al. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. I. Clinical aspects. Dig Dis Sci 1991:36:780-4.
15. Ruoslahti E, Salaspuro M, Pihko H, Andersson L, Seppale M. Serum alpha-fetoprotein: diagnostic significance in liver disease. BMJ 1974;8:527-9.
16. Chen DS, Sung JL. Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in non-malignant disease of the liver. Cancer 1979;44:984-92.
17. Hirai H. Model systems of AFP and CEA expression. Methods Cancer Res 1979;18:39-97.
18. Taketa K. α-Fetoprotein: reevaluation in hepatology. Hepatology 1990;12:1420-32.
19. Karvountzis GG, Redeker AG. Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann Intern Med 1974; 80:156-60.
20. Bloomer JR, Waldmann TA, McIntire KR, Klatskin G. Serum alpha-fetoprotein in patients with massive hepatic necrosis. Gastroenterology 1977;72:479-92.
21. Chu CM, Liaw YF, Pao CC, Huang MJ. The etiology of acute hepatitis superimposed upon previously unrecognized asymptomatic HBsAg bearing carriers. Hepatology 1989;9:452-6.
22. Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Digestive Dis 1977;22:541-50.
23. Yang SS, Chu NS, Liaw YF. Somatosensory evoked potentials in hepatic encephalopathy. Gastroenterology 1985;89:625-30.
24. Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1988;27:857-61.
25. Miyakawa Y, Mayumi M. Hepatitis G virus-a true hepatitis virus or an accidental tourist? N Engl J Med 1997;336:795-6.
26. Cossart Y. TTV, a common virus, but pathogenic? Lancet 1998;352:164.
27. Yang SS, Wu CH, Chen TH, Huang YY, Huang CS. TT viral infection through blood transfusion: retrospective investigation on patients in a prospective study of post-transfusion hepatitis. World J Gastroenterol 2000;6:70-3.
28. Boyer JL, Klatskin G. Pattern of necrosis in acute viral hepatitis: prognosis of bridging hepatic necrosis (subacute hepatic necrosis). N Engl J Med 1970;283:1063-71.
29. Bernuau D, Poliard A, Feldmann G. In situ cellular analysis of α-fetoprotein gene expression in regenerating rat liver after partial hepatectomy. Hepatology 1988;8:997-1005.
30. Yamada H, Toda G, Yoshiba M, Hashimoto N, Ikeda Y, Mitsui H, et al. Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant liver failure. Hepatology 1994;19:1133-40.
31. Lake JR, Sussman NL. Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer. Hepatology 1995;21:879-82.
32. Chen DS. Hepatitis B virus infection, its sequence and prevention in Taiwan. In: Okuda K, Ishak KG, editors. Neoplasms of the liver. Heidelberg Berlin New York Tokyo: Springer-Verlag; 1987. p. 71-80.
33. Liaw YF, Yang SS, Chen TR, Chu CM. Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis: a clinicopathological study. J Hepatol 1985;1:227-33.
34. Chu CM, Sheen IS, Liaw YF. The aetiology of acute hepatitis in Taiwan: acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier rate. Infection 1988;16:233-7.
35. Malik AH, Lee WM. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med 2000;132:723-31.